Compare ResMed Inc. (RMD) vs Waste Management, Inc. (WM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Waste Management, Inc. — how do they compare? ResMed Inc. trades at $230.05 (market cap $31.89B), while Waste Management, Inc. trades at $208.83 (market cap $83.98B). The key difference: Waste Management, Inc. is far larger — about 2.6× ResMed Inc.'s market cap, and Waste Management, Inc. pays the higher dividend (1.8%). Which is the better fit depends on your goals — on Pluang, investors hold ResMed Inc. for 51 Days and Waste Management, Inc. for 130 Days on average.
| RMD | WM | |
|---|---|---|
Market Cap | $31.89B | $83.98B |
Volume | 618,314 | 2,182,180 |
Sector | Health | Industrials |
52-Week High | $275.96 | $246.51 |
52-Week Low | $182.82 | $196.77 |
Typical Hold Time | 51 Days | 130 Days |
Enterprise Value | $31.24B | $106.78B |
Dividend Yield | 1.16% | 1.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $226.73, up 0.33% today, with a bullish technical signal from moving averages and a neutral RSI. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15 billion in 2025, with a net income margin of 26.94%, while cash flow from operations reached $1.75 billion. Recent news highlights an upcoming Q1 2027 earnings report and management's focus on 12%-14% EPS growth driven by demand in sleep therapy.
The outlook for RMD is positive, supported by robust fundamentals and analyst consensus, though risks include competitive pressures and ongoing legal investigations. Upside potential exists with a consensus price target of $242.70, representing a 7% increase from current levels, but investors should monitor execution against growth targets and market share dynamics.
WM trades at $210.10, up 0.56% today, with a bullish technical signal and strong profitability metrics including a 29.83% ROE. Recent earnings have mostly beaten expectations, and the company maintains a solid dividend. Revenue grew to $25.20 billion in 2025, though net income margin dipped to 10.74%. Analyst consensus is strongly positive with no sell ratings.
The outlook for WM is favorable due to consistent cash flow, pricing power, and strategic acquisitions. Risks include elevated debt levels and sensitivity to economic cycles. With a P/E of 29.72, the stock is priced for growth, supported by bullish analyst sentiment and defensive business model strengths.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
